-
公开(公告)号:ES2058083T3
公开(公告)日:1994-11-01
申请号:ES87113278
申请日:1987-09-11
Applicant: BASF AG
Inventor: MOELLER ACHIM DR , EMLING FRANZ DR
IPC: G01N33/53 , A61K39/395 , A61P29/00 , A61P31/04 , A61P35/00 , C07H21/04 , C07K14/00 , C07K14/005 , C07K14/195 , C07K14/52 , C07K14/525 , C07K16/00 , C07K16/24 , C12N5/10 , C12N5/20 , C12N15/00 , C12N15/02 , C12P21/00 , C12P21/08 , C12R1/91 , G01N33/577
Abstract: The monoclonal antibodies are directed highly specifically against human tumour necrosis factor and are synthesised by hybridoma cell lines prepared as described. … …
-
公开(公告)号:DE3787241D1
公开(公告)日:1993-10-07
申请号:DE3787241
申请日:1987-09-11
Applicant: BASF AG
Inventor: MOELLER ACHIM DR , EMLING FRANZ DR
IPC: G01N33/53 , A61K39/395 , A61P29/00 , A61P31/04 , A61P35/00 , C07H21/04 , C07K14/00 , C07K14/005 , C07K14/195 , C07K14/52 , C07K14/525 , C07K16/00 , C07K16/24 , C12N5/10 , C12N5/20 , C12N15/00 , C12N15/02 , C12P21/00 , C12P21/08 , C12R1/91 , G01N33/577
Abstract: The monoclonal antibodies are directed highly specifically against human tumour necrosis factor and are synthesised by hybridoma cell lines prepared as described. … …
-
公开(公告)号:DE4120327A1
公开(公告)日:1992-12-24
申请号:DE4120327
申请日:1991-06-20
Applicant: BASF AG
Inventor: SCHMIDT ULRICH PROF DR , GRIESSER HELMUT , HAAS GERHARD DR , KRONER MATTHIAS DR , RIEDL BERND , EMLING FRANZ DR , HAUPT ANDREAS DR , KLUGE MICHAEL DR
Abstract: Described are peptides of formula (I), in which R , R , R , R , R , X and X are as defined in the description, as well as their preparation. The new peptides are suitable for use in the treatment of illnesses.
-
公开(公告)号:HU0004648A2
公开(公告)日:2001-05-28
申请号:HU0004648
申请日:1998-10-05
Applicant: BASF AG
Inventor: BACH ALFRED DR , DULLWEBER UTA , EMLING FRANZ DR , GARCIA-LADONA XAVIER , LUBISCH WILFRIED DR , STARCK DOROTHEA , STEINER GERD DR , TESCHENDORF HANS-JUERGEN DR , WICKE KARSTEN DR
IPC: A61K31/519 , A61P1/00 , A61P1/14 , A61P3/04 , A61P5/00 , A61P9/12 , A61P15/00 , A61P25/00 , A61P25/22 , A61P25/24 , A61P25/28 , A61P43/00 , C07D471/00 , C07D471/04
Abstract: 3-substituted tetrahydropyridopyrimidinone derivatives of the formula (I) wherein the radicals have the meanings given in the Description, to a method for producing said derivatives and, to their use for producing active ingredients for drugs.
-
公开(公告)号:DE19724979A1
公开(公告)日:1998-12-17
申请号:DE19724979
申请日:1997-06-13
Applicant: BASF AG
Inventor: STEINER GERD DR , DULLWEBER UTA DR , STARCK DOROTHEA DR , BACH ALFRED DR , WICKE KARSTEN DR , TESCHENDORF HANS-JUERGEN DR , GARCIA-LADONA XAVIER DR , EMLING FRANZ DR
IPC: A61K31/505 , A61K31/519 , A61P25/00 , A61P25/24 , A61P43/00 , C07D495/14 , A61K31/55
Abstract: The invention relates to 3-substituted 3,4,5,6,7,8-hexahydro-pyrido [3',4':4,5] thieno [2,3-d] pyrimidine derivatives of formula (I) wherein R is a hydrogen atom, a C1-C4 alkyl group, an acetyl group, a phenyl alkyl C1-C4 radical, the aromatic being optionally substituted by halogen, C1-C4 alkyl, trifluoromethyl, hydroxy, C1-C4 alkoxy, amino, cyano or nitro groups, or a phenylalkanon radical in which the phenyl group can be substituted by halogen, R means a phenyl, pyridyl, pyrimidinyl or pyrazinyl group which is optionally mono- or disubstituted by halogen atoms, C1-C4 alkyl, trifluoromethyl, trifluoromethoxy, hydroxy, C1-C4 alkoxy, amino, monomethylamino, dimethylamino, cyano or nitro groups and said group can be optionally anellated with a benzene nucleus which can be optionally mono- or disubstituted by halogen atoms, C1-C4 alkyl, hydroxy, trifluoromethyl, C1-C4 alkoxy, amino, cyano or nitro groups and may contain one nitrogen atom, or with a 5 or 6-membered ring which may contain 1-2 oxygen atoms, A represents NH or an oxygen atom, Y is CH2, CH2-CH2, CH2-CH2-CH2 or CH2CH, Z represents a nitrogen atom, carbon atom or CH and the bond between Y and Z can also be a double bond, and n represents the number 2, 3 or 4. The invention also relates to the physiologically compatible salts of the inventive 3-substituted pyrido [3',4':4,5] thieno [2,3-d] pyrimidine derivatives. The inventive compounds show a high level of affinity for the serotonin receptors 5-HT1B, 5-HT1D and 5-HT1A. The affinity for said receptors is approximately equal, at least on the same scale. Some of the inventive compounds also have a good capacity for inhibiting serotonin reuptake, a property used in most antidepressants.
-
公开(公告)号:CZ9703765A3
公开(公告)日:1998-06-17
申请号:CZ376597
申请日:1996-06-03
Applicant: BASF AG
Inventor: HAUPT ANDREAS DR , EMLING FRANZ DR , ROMERDAHL CYNTHIA A DR
-
17.
公开(公告)号:CZ9703763A3
公开(公告)日:1998-06-17
申请号:CZ376397
申请日:1996-06-03
Applicant: BASF AG
Inventor: HAUPT ANDREAS DR , EMLING FRANZ DR , ROMERDAHL CYNTHIA A DR
-
公开(公告)号:AT93895T
公开(公告)日:1993-09-15
申请号:AT87113278
申请日:1987-09-11
Applicant: BASF AG
Inventor: MOELLER ACHIM DR , EMLING FRANZ DR
IPC: A61K39/395 , C12N15/00 , C12P21/00 , G01N33/577
-
公开(公告)号:AT82329T
公开(公告)日:1992-11-15
申请号:AT87108847
申请日:1987-06-20
Applicant: BASF AG
-
公开(公告)号:DE19724980A1
公开(公告)日:1998-12-17
申请号:DE19724980
申请日:1997-06-13
Applicant: BASF AG
Inventor: STEINER GERD DR , DULLWEBER UTA DR , STARCK DOROTHEA DR , BACH ALFRED DR , WICKE KARSTEN DR , TESCHENDORF HANS-JUERGEN DR , GARCIA-LADONA FRANCISCO-JAVI D , EMLING FRANZ DR
IPC: A61K31/495 , A61K31/519 , A61P25/00 , A61P25/24 , A61P43/00 , C07D495/04 , A61K31/505 , A61K31/55
Abstract: The invention relates to 3-substituted 3,4 dihydro-thieno[2, 3-d] pyrimidine derivatives of formula (I) wherein R and R mean a hydrogen atom or a C1-C4 alkyl group, R represents a phenyl, pyridyl, pyrimidinyl or pyrazinyl group optionally mono- or disubstituted by halogen atoms, C1-C4 alkyl, trifluoromethyl, trifluoromethoxy, hydroxy, C1-C4 alkoxy, amino, monomethylamino, dimethylamino, cyano or nitro groups, said group being optionally anellated with a benzene nucleus which is optionally mono- or disubstituted by halogen atoms, C1-C4 alkyl, hydroxy, trifluoromethyl, C1-C4 alkoxy, amino, cyano or nitro groups and may contain optionally 1 nitrogen atom, or with a 5 or 6-membered ring which may contain 1-2 oxygen atoms, A represents NH or an oxygen atom, Y is CH2, CH2-CH2, CH2-CH2-CH2 or CH2-CH, Z represents a nitrogen atom, carbon atom or CH and the bond between Y and Z can also be a double bond, and n is the number 2, 3 or 4. The invention also relates to the physiologically compatible salts of the inventive 3-substituted 3,4 dihydro-thieno[2,3-d] pyrimidine derivatives.
-
-
-
-
-
-
-
-
-